THE INCIDENCE OF PROSTATE CANCER IN A SCREENING POPULATION WITH A SERUM PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.: RELATION TO BIOPSY STRATEGY
- 1 March 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6), 757-760
- https://doi.org/10.1097/00005392-200103000-00004
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGYJournal of Urology, 2000
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Comparative Analysis of Prostate Specific Antigen and its Indexes in the Detection of Prostate CancerJournal of Urology, 1996
- Tumor Volume and Prostate Specific Antigen: Implications for Early Detection and Defining a Window of CurabilityJournal of Urology, 1995
- Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 YearsJournal of Urology, 1994
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993
- Detection of Clinically Significant Prostate Cancer by Transrectal Ultrasound-Guided Systematic BiopsiesJournal of Urology, 1992
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992
- Prostate‐specific antigen lewels in 1695 men without evidence of prostate cancer: Findings of the American cancer society national prostate cancer detection projectCancer, 1992
- The role of prostate-specific antigen as part of the diagnostic triad and as a guide when to perform a biopsyCancer, 1991